APA (7th ed.) Citation

Petricevic, B., Laengle, J., Singer, J., Sachet, M., Fazekas, J., Steger, G., . . . Bergmann, M. (2013). Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients. Journal of Translational Medicine, 11(1), 2. https://doi.org/10.1186/1479-5876-11-307

Chicago Style (17th ed.) Citation

Petricevic, Branka, Johannes Laengle, Josef Singer, Monika Sachet, Judit Fazekas, Guenther Steger, Rupert Bartsch, Erika Jensen-Jarolim, and Michael Bergmann. "Trastuzumab Mediates Antibody-dependent Cell-mediated Cytotoxicity and Phagocytosis to the Same Extent in Both Adjuvant and Metastatic HER2/neu Breast Cancer Patients." Journal of Translational Medicine 11, no. 1 (2013): 2. https://doi.org/10.1186/1479-5876-11-307.

MLA (9th ed.) Citation

Petricevic, Branka, et al. "Trastuzumab Mediates Antibody-dependent Cell-mediated Cytotoxicity and Phagocytosis to the Same Extent in Both Adjuvant and Metastatic HER2/neu Breast Cancer Patients." Journal of Translational Medicine, vol. 11, no. 1, 2013, p. 2, https://doi.org/10.1186/1479-5876-11-307.